BTIG Research Increases RxSight (NASDAQ:RXST) Price Target to $36.00
RxSight (NASDAQ:RXST – Free Report) had its price objective hoisted by BTIG Research from $29.00 to $36.00 in a report released on Monday morning, FlyOnTheWall reports. Several other research analysts also recently commented on the company. Needham & Company LLC raised their target price on RxSight from $27.00 to $34.00 in a research note on […]